KERX

Keryx Biopharmaceuticals, Inc. Press Releases

$12.66
*  
0.05
0.4%
Get KERX Alerts
*Delayed - data as of Jan. 29, 2015  -  Find a broker to begin trading KERX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Keryx Biopharmaceuticals, Inc. Announces Pricing of $110 Million Public Offering of Common Stock
1/21/2015 7:53:00 PM - GlobeNewswire


Keryx Biopharmaceuticals, Inc. Announces $100 Million Proposed Public Offering of Common Stock
1/20/2015 4:05:00 PM - GlobeNewswire


Dyadic Appoints Michael Tarnok As Chairman Of The Board Of Directors
1/12/2015 8:40:00 AM - PR Newswire
▼-13.29 % Price Change since this news event. The Volume Ratio is 1.16.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Keryx Biopharmaceuticals Announces Transition of Leadership
1/11/2015 10:00:00 PM - GlobeNewswire


Keryx Biopharmaceuticals to Present at the 33rd Annual J.P. Morgan Healthcare Conference
1/7/2015 7:30:00 AM - GlobeNewswire


Keryx Biopharmaceuticals Announces Commercial Launch of AURYXIA(TM) (ferric citrate) Tablets in the United States
12/22/2014 7:30:00 AM - GlobeNewswire


Keryx Biopharmaceuticals Announces Commercial Launch of AURYXIA™ (ferric citrate) Tablets in the United States
12/22/2014 7:30:00 AM - PR Newswire
▼-14.17 % Price Change since this news event. The Volume Ratio is 0.78.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


TG Therapeutics, Inc. Announces Appointment of Kenneth Hoberman to Board of Directors
12/17/2014 8:30:00 AM - GlobeNewswire


Keryx Biopharmaceuticals, Inc. to Present at the Oppenheimer & Co. Inc. 25th Annual Healthcare Conference
12/8/2014 7:30:00 AM - GlobeNewswire


Keryx Biopharmaceuticals Announces Issuance of a New U.S. Patent for Auryxia(TM) (ferric citrate) Covering Orally Administrable Forms
12/4/2014 7:30:00 AM - GlobeNewswire


Auryxia(TM) (Ferric Citrate) Phase 2 Data Published in the American Journal of Kidney Disease
12/2/2014 7:30:00 AM - GlobeNewswire


Keryx Biopharmaceuticals Announces Trade Name Auryxia(TM) for Ferric Citrate
11/17/2014 5:15:00 PM - GlobeNewswire


Keryx Biopharmaceuticals Announces Results From Ferric Citrate Phase 3 Long-Term Safety Extension Study
11/15/2014 10:00:00 AM - GlobeNewswire


Keryx Biopharmaceuticals, Inc. to Present at the Stifel 2014 Healthcare Conference
11/14/2014 8:30:00 AM - GlobeNewswire


Keryx Biopharmaceuticals, Inc. Announces Third Quarter and Nine Month 2014 Financial Results
11/6/2014 7:00:00 AM - GlobeNewswire